High glucose activates nuclear factor of activated T cells in native vascular smooth muscle

Arterioscler Thromb Vasc Biol. 2006 Apr;26(4):794-800. doi: 10.1161/01.ATV.0000209513.00765.13. Epub 2006 Feb 9.

Abstract

Objective: Hyperglycemia has been suggested to play a role in the development of vascular disease associated with diabetes. Atypical Ca2+ signaling and gene expression are characteristic of vascular dysfunction; however, little is known regarding the effects of high glucose on Ca2+-dependent transcription in the vascular wall.

Methods and results: Using confocal immunofluorescence, we show that modest elevation of extracellular glucose (ie, from 2 to 11.5 mmol/L) increased [Ca2+]i, leading to nuclear accumulation of nuclear factor of activated T cells (NFAT) in intact cerebral arteries from mouse. This was accompanied by increased NFAT-dependent transcriptional activity. Both the increase in Ca2+ and NFAT activation were prevented by the ectonucleotidase apyrase, suggesting a mechanism involving the release of extracellular nucleotides. We provide evidence that the potent vasoconstrictors and growth stimulators UTP and UDP mediate glucose-induced NFAT activation via P2Y receptors. NFAT nuclear accumulation was inhibited by the voltage-dependent Ca2+ channel blockers verapamil and nifedipine, the calcineurin inhibitor cyclosporine A, and the novel NFAT blocker A-285222. High glucose also regulated glycogen synthase kinase 3beta and c-Jun N-terminal kinase activity, yielding decreased kinase activity and reduced export of NFAT from the nucleus, providing additional mechanisms underlying the glucose-induced NFAT activation.

Conclusions: Our results identify the calcineurin/NFAT signaling pathway as a potential metabolic sensor for the arterial smooth muscle response to high glucose.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aorta / cytology
  • Aorta / physiology
  • Calcium Signaling
  • Cerebral Arteries / cytology
  • Cerebral Arteries / physiology
  • Dose-Response Relationship, Drug
  • Glucose / metabolism*
  • Glucose / pharmacology
  • In Vitro Techniques
  • Mice
  • Mice, Transgenic
  • Microscopy, Confocal
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / physiology*
  • NFATC Transcription Factors / metabolism*
  • Pyrazoles / pharmacology
  • Receptors, Purinergic P2 / metabolism
  • Receptors, Purinergic P2Y2
  • Transcriptional Activation / drug effects
  • Uridine Diphosphate / pharmacology
  • Uridine Triphosphate / pharmacology
  • Vasoconstriction / drug effects

Substances

  • A 285222
  • NFATC Transcription Factors
  • P2ry2 protein, mouse
  • Pyrazoles
  • Receptors, Purinergic P2
  • Receptors, Purinergic P2Y2
  • purinoceptor P2Y6
  • Uridine Diphosphate
  • Glucose
  • Uridine Triphosphate